首页|甘露醇不同应用时机对急性脑出血患者血肿控制及治疗预后的影响

甘露醇不同应用时机对急性脑出血患者血肿控制及治疗预后的影响

扫码查看
目的 探讨甘露醇不同应用时机对急性脑出血患者血肿控制及治疗预后的影响.方法 130 例接受保守治疗的急性脑出血患者,参照随机数字表法分为对照组(n=65)、观察组(n=65).对照组患者入院明确诊断后即刻给予甘露醇注射液静脉滴注,观察组患者以具体CT检查结果为指导选择即刻或 6 h后给予甘露醇注射液静脉滴注.比较两组血肿控制情况,治疗效果,血清神经功能指标[S100 钙结合蛋白B(S100B)、胰岛素样生长因子-1(IGF-1)、神经元特异性烯醇化酶(NSE)]水平,甘露醇相关不良反应发生情况.结果 治疗 2 d后,观察组患者的血肿体积变化情况优于对照组(Z=2.358,P<0.05),新发出血发生率 1.54%低于对照组的 10.77%(χ2=4.795,P<0.05).治疗 2 周后,观察组患者的治疗总有效率 100.00%高于对照组的 90.77%(P<0.05).入院即刻,两组患者的S100B、IGF-1、NSE水平比较,差异无统计学意义(P>0.05);治疗 2 周后,两组患者的S100B、NSE水平较入院即刻低,IGF-1水平较入院即刻高;且观察组患者的S100B(0.80±0.11)μg/L、NSE(19.82±2.65)ng/ml较对照组相应时间点的(0.92±0.14)μg/L、(22.71±3.68)ng/ml低,IGF-1(326.43±51.98)ng/ml较对照组相应时间点的(278.19±45.21)ng/ml高(P<0.05).治疗期间,两组患者的甘露醇相关不良反应发生率均较低,比较差异无统计学意义(P>0.05).结论 根据CT结果判断甘露醇用药时机可能是一种更为科学的急性脑出血降颅压方式,有助于积极控制血肿并提升治疗效果,且用药时机不同并不会增加相关不良反应的出现.
Effect of different application timing of mannitol on hematoma control and prognosis in patients with acute cerebral hemorrhage
Objective To explore the effect of different application timing of mannitol on hematoma control and prognosis in patients with acute cerebral hemorrhage.Methods 130 patients with acute cerebral hemorrhage who received conservative treatment were divided into a control group(n=65)and an observation group(n=65)according to random number table method.Patients in the control group were given intravenous mannitol injection immediately after admission,while those in the observation group were given intravenous mannitol injection immediately or 6 h later according to specific CT results.Both groups were compared in terms of control of hematoma,treatment effect,serum nerve function index[S100 calcium-binding protein B(S100B),insulin-like growth factor-1(IGF-1),neuron-specific enolase(NSE)]levels and the occurrence of mannitol-related adverse reactions.Results After 2 d of treatment,the hematoma volume change of the observation group was better than that of the control group(Z=2.358,P<0.05),and the incidence of new bleeding of 1.54%was lower than 10.77%of the control group(χ2=4.795,P<0.05).After 2 weeks of treatment,the total effective rate of 100.00%in the observation group was higher than 90.77%in the control group(P<0.05).Immediately after admission,there was no significant difference in S100B,IGF-1 and NSE levels between the two groups(P>0.05).After 2 weeks of treatment,S100B and NSE levels in both groups were lower than those immediately after admission,and IGF-1 levels were higher than those immediately after admission;the observation group had S100B of(0.80±0.11)μg/L and NSE of(19.82±2.65)ng/ml,which were lower than(0.92±0.14)μg/L and(22.71±3.68)ng/ml in the control group;IGF-1 of(326.43±51.98)ng/ml in the observation group was higher than(278.19±45.21)ng/ml in the control group(P<0.05).During the treatment period,the incidence of mannitol-related adverse reactions in both groups was very low,and there was no statistical significance between the two groups(P>0.05).Conclusion Determining the timing of mannitol administration according to cranial CT results may be a more scientific way to reduce cranial pressure in acute cerebral hemorrhage,which is helpful to actively control hematoma and improve therapeutic effect,different timing of administration does not increase the occurrence of related adverse reactions.

Acute cerebral hemorrhageMannitolApplication timingHematoma controlTreatment prognosis

卢伟、朱志强

展开 >

342700 石城县妇幼保健计划生育服务中心(石城县妇幼保健院)外科

342700 石城县人民医院外一科

急性脑出血 甘露醇 应用时机 血肿控制 治疗预后

2024

中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
年,卷(期):2024.19(19)